These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539 [TBL] [Abstract][Full Text] [Related]
6. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238 [TBL] [Abstract][Full Text] [Related]
7. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390 [TBL] [Abstract][Full Text] [Related]
8. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993 [TBL] [Abstract][Full Text] [Related]
9. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Richmond RL; Harris K; de Almeida Neto A Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537 [TBL] [Abstract][Full Text] [Related]
10. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
11. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Sandborn WJ; Tremaine WJ; Leighton JA; Lawson GM; Zins BJ; Compton RF; Mays DC; Lipsky JJ; Batts KP; Offord KP; Hurt RD; Green J Aliment Pharmacol Ther; 1997 Aug; 11(4):663-71. PubMed ID: 9305473 [TBL] [Abstract][Full Text] [Related]
13. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454 [TBL] [Abstract][Full Text] [Related]
14. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo]. Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633 [TBL] [Abstract][Full Text] [Related]
15. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247 [TBL] [Abstract][Full Text] [Related]
16. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Benowitz NL; Zevin S; Jacob P J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Shiffman S; Elash CA; Paton SM; Gwaltney CJ; Paty JA; Clark DB; Liu KS; Di Marino ME Addiction; 2000 Aug; 95(8):1185-95. PubMed ID: 11092066 [TBL] [Abstract][Full Text] [Related]
20. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Benowitz NL; Zevin S; Jacob P Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]